trolamine salicylate has been researched along with Hemorrhagic Fever, Ebola in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costa-Martins, AG; do Nascimento, APB; Dominguez Crespo Hirata, T; Ferreira, DM; Gonzalez Dias Carvalho, PC; Haks, MC; Harandi, AM; Huttner, A; Mano Alves, LY; Martinez-Murillo, P; Medaglini, D; Moscardini, IF; Nakaya, HI; Ottenhoff, THM; Santoro, F; Siegrist, CA; Sorgi, S; Vianello, E | 1 |
| Addo, MM; Adegnika, AA; Agnandji, ST; Altfeld, M; Auderset, F; Bache, EB; Becker, S; Bejon, P; Biedenkopf, N; Borregaard, S; Brosnahan, JS; Burrow, R; Combescure, C; Dahlke, C; Dayer, JA; Desmeules, J; Eickmann, M; Fast, P; Fehling, SK; Fernandes, JF; Finckh, A; Goncalves, AR; Grobusch, MP; Hooper, J; Huttner, A; Jambrecina, A; Kabwende, AL; Kaiser, L; Kasonta, R; Kaya, G; Kieny, MP; Kimani, D; Kraehling, V; Kremsner, PG; Krishna, S; Lell, B; Lemaître, B; Lohse, AW; Massinga-Loembe, M; Matthey, A; Moorthy, V; Mordmüller, B; Njuguna, P; Nolting, A; Ogwang, C; Ramharter, M; Schmidt-Chanasit, J; Schmiedel, S; Siegrist, CA; Silvera, P; Stahl, FR; Staines, HM; Strecker, T; Stubbe, HC; Tsofa, B; Yerly, S; Zaki, S; Zinser, ME | 1 |
| Auderset, F; Becker, S; Combescure, C; Dayer, JA; Desmeules, J; Eickmann, M; Fast, PE; Finckh, A; Goncalves, AR; Hooper, JW; Huttner, A; Kaiser, L; Kaya, G; Kieny, MP; Krähling, V; Kwilas, S; Lemaître, B; Matthey, A; Moorthy, V; Siegrist, CA; Silvera, P; Yerly, S | 1 |
| Brooks, T; Brown, C; Deen, G; Helderman, T; Howlett, P; Lado, M; Lisk, D; Solbrig, M | 1 |
2 trial(s) available for trolamine salicylate and Hemorrhagic Fever, Ebola
| Article | Year |
|---|---|
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe.
Topics: Adult; Antibodies, Viral; Arthritis; Dermatitis; Double-Blind Method; Ebola Vaccines; Ebolavirus; Exanthema; Female; Hemorrhagic Fever, Ebola; Humans; Male; Membrane Glycoproteins; Middle Aged; Recombinant Proteins; Vesiculovirus; Viral Envelope Proteins; Viremia; Virus Shedding | 2016 |
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial.
Topics: Adolescent; Adult; Aged; Antibodies, Viral; Antigens, Viral; Arthritis; Dermatitis; Double-Blind Method; Drug Carriers; Drug-Related Side Effects and Adverse Reactions; Ebola Vaccines; Ebolavirus; Female; Hemorrhagic Fever, Ebola; Humans; Male; Middle Aged; Placebos; Switzerland; Vaccination; Vaccines, Synthetic; Vasculitis; Vesiculovirus; Young Adult | 2015 |
2 other study(ies) available for trolamine salicylate and Hemorrhagic Fever, Ebola
| Article | Year |
|---|---|
Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts.
Topics: Antibodies, Viral; Arthritis; Ebola Vaccines; Ebolavirus; Headache; Hemorrhagic Fever, Ebola; Humans; Vaccination | 2023 |
Ebola Virus Disease Complicated by Late-Onset Encephalitis and Polyarthritis, Sierra Leone.
Topics: Adult; Arthritis; Ebolavirus; Encephalitis; Epidemics; Female; Hemorrhagic Fever, Ebola; Humans; Sierra Leone | 2016 |